Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q2 2022 · 10-Q
Revenue$276.23M$276.23M+16.3% vs Q2 2021 Net Income$45.33M$45.33M+1.7% vs Q2 2021 EPS Diluted$0.89$0.89+1.1% vs Q2 2021 Gross Profit$157,712,000+14.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$61,194,000+17.4% Free Cash Flowderived$58,442,000+35.7% Margins · derivedGross margin57.1%−0.9 pt vs Q2 2021
Operating margin28.4%−2.3 pt vs Q2 2021
Net margin16.4%−2.4 pt vs Q2 2021
ended Sep 30, 2021 · filed Nov 4, 2021 · 35 d after period end